Literature DB >> 4595553

A quantitative evaluation of the effects of L-dopa on Parkinson's disease.

F Velasco, M Velasco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4595553     DOI： 10.1016/0028-3908(73)90079-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  10 in total

1.  The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Authors:  M Jahanshahi; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status.

Authors:  S L Pullman; R L Watts; J L Juncos; J N Sanes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

3.  Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.

Authors:  Helen Ling; Luke A Massey; Andrew J Lees; Peter Brown; Brian L Day
Journal:  Brain       Date:  2012-03-06       Impact factor: 13.501

Review 4.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

5.  Characteristics of the sequence effect in Parkinson's disease.

Authors:  Suk Yun Kang; Toshiaki Wasaka; Ejaz A Shamim; Sungyoung Auh; Yoshino Ueki; Grisel J Lopez; Tetsuo Kida; Seung-Hyun Jin; Nguyet Dang; Mark Hallett
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

6.  Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease.

Authors:  F Girotti; F Carella; M P Grassi; P Soliveri; R Marano; T Caraceni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

7.  Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation.

Authors:  D Prasher; L Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

8.  Usefulness of movement time in the assessment of Parkinson's disease.

Authors:  M Zappia; R Montesanti; R Colao; A Quattrone
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

9.  Assessment of hypokinesia in Parkinsonism.

Authors:  H Teräväinen; D B Calne
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

10.  Quantifying upper limb motor impairment in people with Parkinson's disease: a physiological profiling approach.

Authors:  Lewis A Ingram; Vincent K Carroll; Annie A Butler; Matthew A Brodie; Simon C Gandevia; Stephen R Lord
Journal:  PeerJ       Date:  2021-02-05       Impact factor: 2.984
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.